Fromowitz, Ariel
Verma, Amit http://orcid.org/0000-0001-7592-7693
Article History
First Online: 27 May 2022
Competing interests
: A.V. has received research funding from Prelude, BMS, GSK, Incyte, Medpacto, Curis and Eli Lilly; is a scientific advisor for Stelexis, Bakx and Curis; receives honoraria from Stelexis and Janssen; and holds equity in Stelexis, Bakx and Throws Exception.
Free to read: This content has been made available to all.